A- A A+

Jung-Jyh Hung (洪榮志)

Jung-Jyh Hung(洪榮志)

簡介

學歷
  1. 國立陽明大學醫學系畢業
  2. 國立陽明大學臨床醫學研究所博士
經歷 現職:
  1. - 迄今 國立陽明交通大學醫學系外科專任教授
  2. - 迄今 台北榮民總醫院外科部胸腔外科主治醫師
經歷:
  1. - 臺北榮民總醫院胸腔外科住院醫師及總醫師
  2. - 臺北榮民總醫院胸腔外科主治醫師
  3. - 國泰綜合醫院胸腔外科專任主治醫師
  4. - 國立陽明大學醫學院外科學系部定教授
醫療專長
  1. 胸腔鏡微創手術(包含肺部毛玻璃病灶、肺癌、食道癌、縱膈腔腫瘤、肺部轉移癌症、氣胸、血胸、膿胸等各類胸腔疾病之手術)
證照
  1. 外科專科醫師
  2. 胸腔及心臟血管外科專科醫師及專科訓練指導醫師
  3. 胸腔暨重症加護專科醫師
  4. 肺癌專科醫師及臨床訓練指導醫師
  5. 重症醫學專科醫師及專科訓練指導醫師

著作

 台灣消化系外科醫學會2007年最佳學術海報獎

台灣胸腔及心臟血管外科學會2008年新秀論文獎

台灣胸腔及心臟血管外科學會2009年理事長論文獎

台灣胸腔及心臟血管外科學會2010年理事長論文獎

台灣胸腔暨重症加護醫學會2013優秀原著論文獎  Young Investigator Award

台灣胸腔暨重症加護醫學會2014優秀原著論文獎  Young Investigator Award

11th International Conference of the Asian Clinical Oncology Society (ACOS) Merit   

Award (2014)

中央研究院2016年輕學者研究著作獎

台灣胸腔及心臟血管外科學會2018年理事長論文獎

第24屆台灣癌症聯合學術年會2019優秀論文獎『基轉組』第一名

台灣胸腔及心臟血管外科學會2019年理事長論文獎

  1. Hung JJ,* Kao YS, Huang CH, et al. Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells. Sci Rep 2019;9:2991. (SCI, IF: 3.998) (*Corresponding author)
  2. Lin YH, Hung JJ,* Yeh YC, et al. Prognostic significance of basal versus superior segment in patients with completely resected lung adenocarcinoma in the lower lobe. Thorac Cancer 2019;10:312-320. (SCI, IF: 2.610) (*Corresponding author)
  3. Hung JJ,* Yeh YC, Hsu WH. Prognostic significance of aldo-keto reductase family 1 member B10 in patients with resected lung adenocarcinoma. Thorac Cancer 2018;9:1492-1499. (SCI, IF: 2.610) (*Corresponding author)
  4. Hung JJ,* Yeh YC, Wu YC, et al. Prognostic Factors in Completely Resected Node-negative Lung Adenocarcinoma of 3cm or Smaller. J Thorac Oncol 2017;12:1824-1833. (SCI, IF: 13.357) (*Corresponding author)
  5. Hung JJ, Wu YC, Chou TY, et al. Adjuvant Chemotherapy Improves the Probability of Freedom from Recurrence in Patients with Resected Stage IB Lung Adenocarcinoma. Ann Thorac Surg 2016;101:1346-1353. (SCI, IF: 3.639)
  6. Hung JJ,* Yeh YC, Jeng WJ, et al. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3cm or smaller. Eur J Cardiothorac Surg 2016;50:329-336. (SCI, IF 3.486) (*Corresponding author)
  7. Hung JJ,* Yeh YC, Jeng WJ, et al. Prognostic Factors of Survival after Recurrence in Patients with Resected Lung Adenocarcinoma. J Thorac Oncol 2015;10:1328-1336. (SCI, IF: 13.357) (*Corresponding author)
  8. Hung JJ, Yeh YC, Jeng WJ, et al. Predictive Value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Tumor Recurrence and Patient Survival. J Clin Oncol 2014;32:2357-2364. (SCI, IF: 32.956)
  9. Hung JJ,* Jeng WJ, Chou TY, et al. Prognostic Value of the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Lung Adenocarcinoma Classification on Death and Recurrence in Completely Resected Stage I Lung Adenocarcinoma. Ann Surg 2013;258:1079-86. (SCI, IF: 10.130) (*Corresponding author)
  10. Liu CY, Hung JJ,* Wang BY, et al. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Eur Respir J 2013;41:649-55. (SCI, IF: 12.339) (*Co-first author)
  11. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer. Chest 2012;142:141-50. (SCI, IF: 8.308) (*Corresponding author)
  12. Hung JJ,* Jeng WJ, Hsu WH, et al. Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer. J Thorac Oncol 2012;7:397-405. (SCI, IF: 13.357) (*Corresponding author)
  13. Hung JJ, Jeng WJ, Hsu WH, et al. Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non-Small-Cell Lung Cancer. J Thorac Oncol 2012;7:1115-23. (SCI, IF: 13.357)
  14. Hung JJ,* Jeng WJ, Hsu WH, et al. Prognostic factors of post-recurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-5. (SCI, IF: 8.834) (*Corresponding author)
  15. Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors in pathological stage IB non-small cell lung cancer greater than 3 cm. Eur Respir J 2010;36:1355-61. (SCI, IF: 12.339)
  16. Hung JJ, Hsu WH, Hsieh CC, et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6. (SCI, IF: 8.834)
  17. Hung JJ, Yang MH, Hsu HS, et al. Prognostic significance of hypoxia-inducible factor-1a, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009;64:1082-9. (SCI, IF: 8.834)
  18. Hung JJ, Wang CY, Huang MH, et al. Prognostic Factors in Resected Stage I Non-small Cell Lung Cancer of Diameter 3 cm or Less: Visceral pleural invasion did not influence overall and disease-free survival. J Thorac Cardiovasc Surg 2007;134:638-43. (SCI, IF: 4.451)